Intravitreal Steroids: Balancing Effective Use With Intraocular Pressure Control
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
This certified CME activity is designed for retina specialists, glaucoma specialists and general ophthalmologists involved in the management of patients with retinal and glaucomatous disease. Learning Objectives
Upon completion of this activity, the participant should be able to: • Understand the potential for corticosteroid therapy to induce complications, including elevated IOP • Distinguish between the different classes of corticosteroid therapy and relate the risks for complications associated with each • Explain the early warning signs of elevated IOP • Identify effective management strategies for patients requir- ing intervention Disclaimer
In accordance with the disclosure policies of the Dulaney Foundation and to conform with ACCME and US Food and Drug Administration guidelines, anyone in a position to affect the content of a CME activity is required to disclose to the activity participants (1) the existence of any financial interest or other relationships with the manufacturers of any commercial products/devices or providers of commercial services and (2) identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
